Autolus Therapeutics (AUTL) Exchange Rate Effect (2018 - 2025)

Autolus Therapeutics (AUTL) has reported Exchange Rate Effect for 8 consecutive years, with $589000.0 the latest figure, recorded in Q4 2025.

• Quarterly Exchange Rate Effect rose 101.54% year-over-year to $589000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 million (up 2505.75% YoY) and the FY2025 annual result came in at $6.3 million, up 2505.75% from the prior year.
• Exchange Rate Effect grew to $589000.0 in Q4 2025 per AUTL's latest filing, from -$3.6 million in the prior quarter.
• Over the last five years, Exchange Rate Effect for AUTL reached as high as $37.7 million in Q3 2024 and fell as low as -$38.2 million in Q4 2024.
• A 5-year average of -$404100.0 and a median of $1.0 million in 2021 frame the typical range for Exchange Rate Effect.
• The largest YoY upside for Exchange Rate Effect was 1409.95% in 2022 against a maximum downside of 1502.55% in 2022.
• Year by year, Exchange Rate Effect stood at $734000.0 in 2021, then surged by 1409.95% to $11.1 million in 2022, then fell by 11.82% to $9.8 million in 2023, then slumped by 491.04% to -$38.2 million in 2024, then soared by 101.54% to $589000.0 in 2025.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered $589000.0, -$3.6 million, and $5.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.